Detection of yeasts in blood cultures by the luminex xTAG fungal assay

Journal of Clinical Microbiology

Volumn 50, Issue 2, 2012, Pages 492-494

  Balada Llasat, Joan Miquel ^a   LaRue, Heidi ^a   Kamboj, Kamal ^a   Rigali, Lisa ^a   Smith, Debra ^a   Thomas, Keelie ^a   Pancholi, Preeti ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; REAGENT;

ABIOTROPHIA; ALPHA HEMOLYTIC STREPTOCOCCUS; ANALYTIC METHOD; ARTICLE; ASSAY; AUREOBASIDIUM PULLULANS; BACTEROIDES FRAGILIS; BLASTOMYCES DERMATITIDIS; BLOOD CULTURE; BLOOD CULTURE BOTTLE; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA NORVEGENSIS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CHRYSEOMONAS; CLAVISPORA LUSITANIAE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMPUTER PROGRAM; CONTAINER; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; ENTEROBACTER; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FUNGAL DETECTION; GENE AMPLIFICATION; HISTOPLASMA CAPSULATUM; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MICROORGANISM; MULTIPLEX POLYMERASE CHAIN REACTION; PICHIA GUILLIERMONDII; PREDICTIVE VALUE; PRIORITY JOURNAL; RHODOTORULA; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; YEAST;

BLOOD; FUNGEMIA; HUMANS; MICROBIOLOGICAL TECHNIQUES; MULTIPLEX POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; YEASTS;

AJELLOMYCES CAPSULATUS; AJELLOMYCES DERMATITIDIS; CANDIDA; FILOBASIDIELLA NEOFORMANS;

EID: 84862907490     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.06375-11     Document Type: Article

References (22)

1. Avni T, Leibovici L, Paul M. 2011. PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J. Clin. Microbiol. 49:665-670.
2. Babady NE, Miranda E, Gilhuley KA. 2011. Evaluation of Luminex xTAG fungal analyte-specific reagents for rapid identification of clinically relevant fungi. Clin. Microbiol. 49:3777-3782.
3. Balada-Llasat JM, LaRue H, Kelly C, Rigali L, Pancholi P. 2011. Evaluation of commercial ResPlex II v2.0, MultiCode-PLx, and xTAG respiratory viral panels for the diagnosis of respiratory viral infections in adults. J. Clin. Virol. 50:42-45.
4. Bovers M, et al. 2007. Identification of genotypically diverse Cryptococcus neoformans and Cryptococcus gattii isolates by Luminex xMAPtechnology. J. Clin. Microbiol. 45:1874-1883. (Pubitemid 46933920)
5. Deak E, et al. 2010. Utility of a Luminex-based assay for multiplexed, rapid species identification of Candida isolates from an ongoing candidemia surveillance. Can. J. Microbiol. 56:348-351.
6. De Pauw B, et al. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46:1813-1821.
7. Dunbar SA. 2006. Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection. Clin. Chim. Acta 363:71-82. (Pubitemid 41745226)
8. Etienne KA, Kano R, Balajee SA. 2009. Development and validation of a microsphere-based Luminex assay for rapid identification of clinically relevant aspergilli. J. Clin. Microbiol. 47:1096-1100.
9. Fernandez J, Erstad BL, Petty W, Nix DE. 2009. Time to positive culture and identification for Candida blood stream infections. Diagn. Microbiol. Infect. Dis. 64:402-407.
10. Ferroni A, et al. 2010. Real-time identification of bacteria and Candida species in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 48:1542-1548.
11. Forrest GN, et al. 2006. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J. Clin. Microbiol. 44:3381-3383. (Pubitemid 44413783)
12. Garey KW, et al. 2006. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin. Infect. Dis. 43:25-31. (Pubitemid 43939072)
13. Iatta R, Caggiano G, Cuna T, Montagna MT. 2011. Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia. J. Chemother. 23:92-96.
14. Marinach C, et al. 2009. MALDI-TOF MS-based drug susceptibility testing of pathogens: the example of Candida albicans and fluconazole. Proteomics 9:4627-4631.
15. Marklein G, et al. 2009. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J. Clin. Microbiol. 47:2912-2917.
16. McMullan R, et al. 2008. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults. Clin. Infect. Dis. 46:890-896. (Pubitemid 351417192)
17. Pappas PG, et al. 2009. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48:503-535.
18. Perlin DS. 2009. Antifungal drug resistance: do molecular methods provide a way forward? Curr. Opin. Infect. Dis. 22:568-573.
19. Pfaller MA, et al. 2001. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J. Clin. Microbiol. 39:3254-3259. (Pubitemid 32830323)
20. Reller ME, Mallonee AB, Kwiatkowski NP, Merz WG. 2007. Use of peptide nucleic acid-fluorescence in situ hybridization for definitive, rapid identification of five common Candida species. J. Clin. Microbiol. 45: 3802-3803. (Pubitemid 350156889)
21. Sheppard DC, Locas MC, Restieri C, Laverdiere M. 2008. Utility of the germ tube test for direct identification of Candida albicans from positive blood culture bottles. J. Clin. Microbiol. 46:3508-3509.
22. Tortorano AM, et al. 2004. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur. J. Clin. Microbiol. Infect. Dis. 23:317-322. (Pubitemid 38669942)